Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells

Neoplasia

Volumn 3, Issue 4, 2001, Pages 278-286

  Liu, Xuesong ^a   Shi, Yan ^a   Han, Edward K H ^a   Chen, Zehan ^a   Rosenberg, Saul H ^a   Giranda, Vincent L ^a   Luo, Yan ^a   Ng, Shi Chung ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Akt1; Antisense; Apoptosis; Cancer; Combination treatment; Oligonucleotide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE; DOXORUBICIN; ETOPOSIDE; ISIS 28949; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN SERINE THREONINE KINASE;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CARCINOGENICITY; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIZATION; ENZYME INHIBITION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034868089     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900163     Document Type: Article

References (46)

1. Apoptosis in the pathogenesis and treatment of disease
2. Cell death in development
3. The hallmarks of cancer
4. Cellular survival: A play in three Akts
5. Transforming ability of MEN2A-RET requires activation of the phosphotidylinositol 3-kinase/AKT signaling pathway
6. A retroviral oncogene, akt, encoding a serine threonine kinase containing a SH2-like region
7. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
8. Molecular cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
9. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3
10. The protein kinase encoded by the akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
11. Mechanism of activation of protein kinase B by insulin and IGF-1
12. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-triphosphate-dependent activation of protein kinase B
13. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
14. Involvement of the pleckstrin homology domain in the insulin-stimulated activation of protein kinase B
15. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RACPK/PKB) promoted by serum and protein phosphatase inhibitors
16. Akt, a pleckstrin domain containing kinase, is activated primarily by phosphorylation
17. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B α
18. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells
19. Akt/Protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
20. Akt is more than just a Bad kinase
21. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery
22. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
23. Regulation of cell death protease caspase-9 by phosphorylation
24. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
25. The PTEN/MSAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
26. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancers
27. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of Akt1 in a primary human gastric adenocarcinoma
28. Akt2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
29. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
30. Induction of apoptotic program in cell free extract: Requirement for cytochrome c and dATP
31. kip1, inhibits growth, and enhances apoptosis
32. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked
33. Role of phosphotidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase
34. Anti-apoptotic signaling by hepatocyte growth factor/ Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activiated protein kinase pathways
35. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
36. The phosphoinositide 3-OH kinase/Akt2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis
37. Characterization of the p53 tumor suppressor pathway in cell lines of the NCI anticancer drug screen and correlation with growth inhibitory potency of 123 anticancer agents
38. Ras oncogenes in human cancer: A review
39. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells
40. Phosphatidylinositol-3-OH kinase as a direct target of Ras
41. kip1
42. Specific proteolytic cleavage of poly (ADP-ribose) polymerase): An early marker of chemotherapy-induced apoptosis
43. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line
44. Metastatic small-cell carcinoma of rectum responding dramatically to combination chemotherapy
45. Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines
46. Paclitaxel (Taxol)/Carboplantin combination chemotherapy in the treatment of advanced ovarian cancer